Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India.
Curr Pharm Biotechnol. 2024;25(11):1349-1361. doi: 10.2174/1389201024666230703115732.
Ongoing development in cosmetics is increasingly making use of probiotics, which are defined as "live microorganisms with health-enhancing properties mediated through ingestion or topical application to the host". The observation that several bacterial strains augment normal processes of healthy tissue maintenance, particularly for the skin, has opened up new avenues for the use of bacterial strains in cosmetics. A principal feature of such "cosmeceuticals" is an application of increasing insight into the biochemical nature of the skin's normal microbial flora, also called its microbiome. The opportunity of manipulating the skin microbiome to address various skin disorders has revealed novel routes for treatment. The skin microbiome manipulation approaches to address various skin disorders include skin microbiome transplantation, skin bacteriotherapy, and prebiotic stimulation. Research in this field has revealed that medical outcome-targeted manipulation of skin microbiome bacterial strain makeup may significantly increase skin health and appearance. Commercial availability of probiotic skincare products is rapidly expanding worldwide due to satisfactory laboratory results and public perception of probiotics as being intrinsically more wholesome than other bioactive substances, such as synthetics. Major outcomes of probiotic use include a significant reduction in skin wrinkling, acne and other conditions adversely affecting skin appearance and healthy function. Moreover, probiotics may additionally promote normal skin hydration, resulting in a vibrant and lustrous appearance. Nevertheless, significant technical challenges remain for the full optimization of probiotics in cosmetic products. This article summarizes the evolving nature of this field and explores current probiotic research initiatives, along with regulatory aspects and significant challenges in the manufacturing of cosmetics in the context of market expansion for these products.
化妆品行业的持续发展越来越多地利用益生菌,益生菌被定义为“通过摄入或局部应用于宿主而具有增强健康特性的活菌”。观察到几种细菌菌株增强了健康组织维持的正常过程,特别是对皮肤,这为细菌菌株在化妆品中的应用开辟了新的途径。这种“美容护肤品”的一个主要特点是越来越多地了解皮肤正常微生物群的生化性质,也称为其微生物组。操纵皮肤微生物组来解决各种皮肤疾病的机会揭示了新的治疗途径。用于解决各种皮肤疾病的皮肤微生物组操纵方法包括皮肤微生物组移植、皮肤细菌疗法和益生元刺激。该领域的研究表明,针对皮肤微生物组细菌菌株组成的医学结果靶向操纵可能会显著增加皮肤健康和外观。由于令人满意的实验室结果和公众对益生菌作为比其他生物活性物质(如合成物)更天然的看法,益生菌护肤品在全球范围内的商业可用性正在迅速扩大。益生菌使用的主要结果包括显著减少皮肤皱纹、痤疮和其他影响皮肤外观和健康功能的疾病。此外,益生菌还可以促进皮肤正常保湿,使皮肤呈现出充满活力和光泽的外观。然而,在将益生菌充分优化到化妆品产品中仍存在重大技术挑战。本文总结了这一领域的发展变化,并探讨了当前益生菌研究计划,以及在这些产品市场扩张的背景下,化妆品制造的监管方面和重大挑战。
J Microbiol. 2024-3
Arch Dermatol Res. 2017-8
Molecules. 2021-2-26
Benef Microbes. 2014-6-1
J Appl Microbiol. 2024-8-5
Aliment Pharmacol Ther. 2022-7
Probiotics Antimicrob Proteins. 2025-7-7
J Cosmet Dermatol. 2024-12
Microorganisms. 2024-8-19
J Microbiol. 2024-3
Clin Cosmet Investig Dermatol. 2022-11-16
Microorganisms. 2022-5-21
Crit Rev Microbiol. 2023-5
Int J Environ Res Public Health. 2022-5-7
Pharmaceutics. 2022-3-3